X Agirre, A Fontalba, EJ Andreu, MD Odero, MJ Larrayoz, C Montiel, MJ Calasanz, JL Fernandez-Luna and F Prosper (2003) “Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response”, Haematologica. Pavia, Italy, 88(12), pp. 1425-1426. doi: 10.3324/%x.